Incyte (INCY) Interest Coverage Ratio (2010 - 2026)
Incyte (INCY) posted Interest Coverage Ratio of 47.05 for Q1 2026, down 91.85% on a QoQ basis from 577.08 in Q4 2025, and up 33.01% year-over-year from 35.37 in Q1 2025.
Incyte (INCY) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Incyte's Interest Coverage Ratio history runs 17 years deep, the most recent figure standing at 47.05 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 33.01% year-over-year to 47.05 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 87.16 (up 33.75% YoY) and the FY2025 annual result came in at 67.63, up 235699.99% from the prior year.
- Interest Coverage Ratio was 47.05 for Q1 2026 at Incyte, down from 577.08 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 577.08 in Q4 2025 and bottomed at 91.95 in Q2 2024.
- A 5-year average of 56.81 and a median of 28.09 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio tumbled 304.27% — and 2025, when it surged 2687.64%.
- Incyte's Interest Coverage Ratio stood at 5.82 in 2022, then jumped by 287.44% to 10.92 in 2023, then tumbled by 304.27% to 22.3 in 2024, then jumped by 2687.64% to 577.08 in 2025, then sank by 91.85% to 47.05 in 2026.
- Business Quant data shows INCY's Interest Coverage Ratio at 47.05 in Q1 2026, 577.08 in Q4 2025, and 76.47 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | 47.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47.05 |
| Dec 31, 2025 | 577.08 |
| Sep 30, 2025 | 76.47 |
| Jun 30, 2025 | 93.04 |
| Mar 31, 2025 | 35.37 |
| Dec 31, 2024 | -22.30 |
| Sep 30, 2024 | 28.09 |
| Jun 30, 2024 | -91.95 |
| Mar 31, 2024 | 17.02 |
| Dec 31, 2023 | 10.92 |
| Sep 30, 2023 | 42.94 |
| Jun 30, 2023 | 48.45 |
| Mar 31, 2023 | 4.42 |
| Dec 31, 2022 | -5.82 |
| Sep 30, 2022 | 27.13 |
| Jun 30, 2022 | 54.13 |
| Mar 31, 2022 | 23.78 |
| Dec 31, 2021 | 28.39 |
| Sep 30, 2021 | 3.64 |
| Jun 30, 2021 | 2.18 |